Sutro Biopharma
(NASDAQ) STRO
Sutro Biopharma Financials at a Glance
Market Cap
$396.78M
Revenue (TTM)
$102.48M
Net Income (TTM)
$191.09M
EPS (TTM)
$-22.65
P/E Ratio
-1.06
Dividend
$0.00
Beta (Volatility)
1.27 (Average)
Dividend
$0.00
Beta (Volatility)
1.27 (Average)
Price
$25.84
Volume
18,235
Open
$24.89
Price
$25.84
Volume
18,235
Open
$24.89
Previous Close
$25.84
Daily Range
$23.79 - $26.12
52-Week Range
$5.23 - $26.54
Dividend
$0.00
Beta (Volatility)
1.27 (Average)
Price
$25.84
Volume
18,235
Open
$24.89
Previous Close
$25.84
Daily Range
$23.79 - $26.12
52-Week Range
$5.23 - $26.54
STRO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sutro Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
137
CEO
Jane Chung
Website
www.sutrobio.comHeadquarters
South San Francisco, CA 94080, US
STRO Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-1810%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-94.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$396.78M
Shares Outstanding
16.57M
Volume
18.23K
Short Interest
0.00%
Avg. Volume
158.83K
Financials (TTM)
Gross Profit
$95.16M
Operating Income
$104.95M
EBITDA
$97.63M
Operating Cash Flow
$177.23M
Capital Expenditure
$1.70M
Free Cash Flow
$178.93M
Cash & ST Invst.
$141.43M
Total Debt
$15.67M
Sutro Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.65M
-21.4%
Gross Profit
$10.02M
-32.3%
Gross Margin
86.06%
N/A
Market Cap
$396.78M
N/A
Market Cap/Employee
$1.48M
N/A
Employees
269
N/A
Net Income
$46.76M
+35.4%
EBITDA
$32.03M
+46.2%
Quarterly Fundamentals
Net Cash
$93.78M
-131.9%
Accounts Receivable
$3.98M
-53.8%
Inventory
$0.00
N/A
Long Term Debt
$227.43M
+1351.0%
Short Term Debt
$7.78M
+4.1%
Return on Assets
-1.10%
N/A
Return on Invested Capital
-1.56%
N/A
Free Cash Flow
$26.62M
+63.4%
Operating Cash Flow
$26.43M
+63.2%